Status:
COMPLETED
Assessing Risk Factors for Radiological Complications After Transforaminal Lumbar Interbody Fusion
Lead Sponsor:
University Hospital, Basel, Switzerland
Conditions:
Degenerative Lumbar Spine Diseases
Eligibility:
All Genders
55+ years
Brief Summary
This retrospective study is to determine whether age is a risk factor for postoperative complications in patients undergoing transforaminal lumbar interbody fusion; specifically whether the risk (odds...
Detailed Description
Spinal fusion is one of the most commonly performed surgical procedures for the treatment of degenerative spinal disease. Interbody fusion with cages reconstructs the anterior column through disc remo...
Eligibility Criteria
Inclusion
- Indications for TLIF surgery (e.g., degenerative disc disease, spondylolisthesis)
- Existing preoperative upright standing sagittal plane X-ray of lumbar spine with clear visibility of pelvis, sacrum and femoral head
- Existing preoperative MRI of the lumbar region with clear visibility of different fatty infiltration grade and stenosis degree
- Complete follow-up at 3 months and 1 year postoperatively, including clinical and radiographic data
Exclusion
- Neuromuscular diseases such as Parkinson's disease or multiple sclerosis according to our records
- Preoperative infection and/or malignancy tumor with involvement of the bony or soft tissue structures of the lumbar spine
- Presence of a documented consent dissent
Key Trial Info
Start Date :
January 19 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 15 2023
Estimated Enrollment :
170 Patients enrolled
Trial Details
Trial ID
NCT05266638
Start Date
January 19 2022
End Date
February 15 2023
Last Update
February 20 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Basel, Orthopedics and Traumatology
Basel, Switzerland, 4031